Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,343Revenue $M7.0Net Margin (%)-1,030.2Z-Score12.7
Enterprise Value $M1,257EPS $-0.6Operating Margin %-1,027.5F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-1,023.7Higher ROA y-yY
Price/Book16.610-y EBITDA Growth Rate %0Quick Ratio3.1Cash flow > EarningsY
Price/Sales1085-y EBITDA Growth Rate %0Current Ratio3.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-93.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-114.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M91.9ROI % (ttm)-34.8Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 12.41-19%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 12.41-12%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 12.41-17%New holding, 6310850 sh.6,310,850
KERXJohn Burbank 2012-12-31 Sold Out -0.06%$2.31 - $3.14
($2.72)
$ 12.41356%Sold Out0
KERXJohn Burbank 2012-09-30 Buy 0.06%$1.79 - $2.83
($2.08)
$ 12.41497%New holding, 500000 sh.500,000
KERXGeorge Soros 2006-09-30 Sold Out -0.04%$9.8 - $13.84
($12.1)
$ 12.413%Sold Out0
KERXGeorge Soros 2006-06-30 Buy 0.04%$12.64 - $17.44
($15.3)
$ 12.41-19%New holding, 30000 sh.30,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
KERX Seth Klarman 2014-12-3118,300,00019.95.1
Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Madison GregPresident and COO 2015-02-09Sell6,759$10.9511.05view
Oliviero James F IIICFO 2015-01-05Sell5,604$13.79-11.82view
BENTSUR RONCEO 2015-01-05Sell5,574$13.79-11.82view
BENTSUR RONCEO 2014-12-30Sell200,000$14.11-13.82view
BENTSUR RONCEO 2014-12-29Sell338,977$13.98-13.02view
Oliviero James F IIICFO 2014-12-10Sell25,000$15.69-22.5view
BENTSUR RONCEO 2014-10-06Sell70,838$15.88-23.43view
Oliviero James F IIICFO 2014-10-03Sell2,694$16.14-24.66view
BENTSUR RONCEO 2014-09-12Sell50,000$14.24-14.61view
Oliviero James F IIICFO 2014-09-08Sell144,237$15.88-23.43view

Press Releases about KERX :

    Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    Portfolio Feb 16 2015 
    2015 Must-Buys In Biotech Sector Feb 02 2015 
    me Jan 23 2015 
    Seth Klarman Keeps Buying LNG, KERX, PBF And Keeps Selling THRX Dec 05 2014 
    Baupost’s Seth Klarman Buys Cheniere Energy, Ocwen Financial, Antero Resources, Sells Boyd Gaming, Nov 14 2014 
    Seth Klarman’s The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, Sel Aug 14 2014 
    Seth Klarman Tops Guru Scoreboard for First Half 2014 Jul 05 2014 
    Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
    Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD Mar 24 2014 
    Weekly Insider Sells Highlight: FLT, KERX, KOG, MEI, HTZ Jan 06 2014 


    More From Other Websites
    Keryx's (KERX) Q4 Loss Misses Expectation, Auryxia in Focus - Tale of the Tape Feb 27 2015
    Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today Feb 27 2015
    Keryx Biopharma reports 4Q loss Feb 27 2015
    Keryx Biopharma reports 4Q loss Feb 27 2015
    Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences Feb 27 2015
    Q4 2014 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open Feb 27 2015
    7:05 am Keryx Biopharma reports Q4 results Feb 27 2015
    Keryx Announces Fourth Quarter and Year-End 2014 Financial Results Feb 27 2015
    What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Feb 26 2015
    Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2014 Financial... Feb 25 2015
    Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences Feb 25 2015
    Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2014 Financial... Feb 18 2015
    Well-Fed Analysts Stay Mum on Keryx Biopharma's Slow Drug Launch Feb 09 2015
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 27 2015
    Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog Jan 22 2015
    Keryx Biopharmaceuticals (KERX) in Focus: Stock Falls by 6.8% - Tale of the Tape Jan 22 2015
    Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock Jan 21 2015
    Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock Jan 20 2015
    Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock Jan 20 2015
    Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors Jan 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK